Ypsomed Holding AG (YPSN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Ypsomed Holding AG (YPSN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7140
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures injection and infusion systems for self-medication and offers related services. It offers autoinjectors, dual chamber pens, and pen injectors. The company also offers services ranging from design and development projects, flexible prototyping, human factors engineering, and IP landscape management to manufacturing and assembly infrastructure and registration support. Ypsomed offers solutions to physicians, and pharmaceutical and biotechnology companies. The company’s products find application in the treatment of diabetes, infertility, growth disorders and various other clinical indications. The company operates through its subsidiaries and distributors across the world. Ypsomed is headquartered in Burgdorf, Switzerland.

Ypsomed Holding AG (YPSN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ypsomed Holding AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ypsomed Holding AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ypsomed Holding AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ypsomed Holding AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Ypsomed Holding AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ypsomed Holding AG, Medical Equipment, Deal Details 10
Asset Purchase 10
Ypsomed Plans to Acquire Injection System Business in China 10
Partnerships 11
Ypsomed to Enter into Agreement with Philips 11
Bigfoot Biomedical Enters into Agreement with Ypsomed 12
Ypsomed Enters into Distribution Agreement with Tonghua Dongbao Pharma 13
Thin Film Electronics Partners with Ypsomed 14
Ypsomed Partners with Tonghua Dongbao Pharma 15
Insulet Expands Distribution Agreement With Ypsomed Holding 16
Acquisition 17
Ypsomed Plans To Sell DiaExpert, Diabetes Products Provider 17
Ypsomed Holding AG – Key Competitors 18
Ypsomed Holding AG – Key Employees 19
Ypsomed Holding AG – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Strategy And Business Planning 21
Jun 29, 2018: Topping-out ceremony at the new Ypsomed site in Schwerin 21
Sep 27, 2017: Go-ahead for Ypsomed’s new production facility in Schwerin 22
May 10, 2017: Ypsomed expands to more countries 23
Jan 25, 2017: Ypsomed opens a new production line in Solothurn 24
Financial Announcements 25
May 24, 2018: Ypsomed significantly increases turnover and invests more in the future 25
Nov 09, 2017: Ypsomed Grows during First half-year and Raises its Forecast for the Year 27
May 24, 2017: Ypsomed accelerates growth significantly 29
Corporate Communications 31
Jun 27, 2018: Change in the Board of Directors of the Ypsomed Group 31
Other Significant Developments 32
Oct 24, 2017: Ypsomed supplies Bigfoot Biomedical with infusion sets 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Ypsomed Holding AG, Medical Equipment, Key Facts, 2018 2
Ypsomed Holding AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Ypsomed Holding AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ypsomed Holding AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ypsomed Holding AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ypsomed Holding AG, Deals By Market, 2012 to YTD 2018 8
Ypsomed Holding AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ypsomed Plans to Acquire Injection System Business in China 10
Ypsomed to Enter into Agreement with Philips 11
Bigfoot Biomedical Enters into Agreement with Ypsomed 12
Ypsomed Enters into Distribution Agreement with Tonghua Dongbao Pharma 13
Thin Film Electronics Partners with Ypsomed 14
Ypsomed Partners with Tonghua Dongbao Pharma 15
Insulet Expands Distribution Agreement With Ypsomed Holding 16
Ypsomed Plans To Sell DiaExpert, Diabetes Products Provider 17
Ypsomed Holding AG, Key Competitors 18
Ypsomed Holding AG, Key Employees 19
Ypsomed Holding AG, Subsidiaries 20

List of Figures
Ypsomed Holding AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Ypsomed Holding AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Ypsomed Holding AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Ypsomed Holding AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Ypsomed Holding AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ypsomed Holding AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Ypsomed Holding AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ypsomed Holding AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Ypsomed Holding AG (YPSN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Energiekontor AG (EKT):企業の財務・戦略的SWOT分析
    Summary Energiekontor AG (Energiekontor) is a renewable energy company that develops and operates offshore wind farms. The company operates in the field of project development and sales, power generation in group-owned wind farms, and operation development services. Its services include construction …
  • Acteon Group Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Acteon Group Ltd (Acteon) is an oil and gas company that offers subsea services. The company’s services include survey and monitoring data, risers and moorings, seabed foundation technologies and project support services. Its survey and monitoring data services comprise chain monitoring and …
  • Apollo Education Group Inc:企業の戦略的SWOT分析
    Apollo Education Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Cyxone AB (CYXO):製薬・医療:M&Aディール及び事業提携情報
    Summary Cyxone AB (Cyxone) is a biopharmaceutical company that develops cyclotide drugs for immune-related diseases. The company develops T20K, a compound to inhibit pro-inflammatory cytokines, such as IL2 that helps to reduce clinical symptoms in an animal model for multiple sclerosis after oral ad …
  • China Petroleum & Chemical Corp:企業の戦略・SWOT・財務情報
    China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report Summary China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Brainsway Ltd (BRIN):企業の財務・戦略的SWOT分析
    Summary Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It of …
  • Tec-Masters, Inc.:企業の戦略・SWOT・財務情報
    Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Inception Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Inception Sciences Inc (Inception Sciences) is a pharmaceutical company that offers drug discovery incubators. The company develops new companies in partnership with academic researchers and biopharmaceutical companies. It develops drugs for various indications such as fibrotic diseases, onc …
  • BiondVax Pharmaceuticals Ltd (BVXV):企業の財務・戦略的SWOT分析
    Summary BiondVax Pharmaceuticals Ltd (BiondVax Pharmaceuticals) is a biopharmaceutical company that develops universal flu vaccine. The company provides lead product M-001 is a synthetic peptide-based protein that offers protection against human influenza virus strains including seasonal influenza s …
  • GenMark Diagnostics Inc (GNMK)-医療機器分野:企業M&A・提携分析
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that offers clinical testing systems. The company’s products comprise XT-8 systems and ePlex systems. Its pipeline products include eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test and others. G …
  • Amazon.com, Inc.:企業の戦略・SWOT・財務情報
    Amazon.com, Inc. - Strategy, SWOT and Corporate Finance Report Summary Amazon.com, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Eagle Cement Corporation (EAGLE):企業の財務・戦略的SWOT分析
    Eagle Cement Corporation (EAGLE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Cremonini S.p.A. (Foodservice):企業の戦略・SWOT・財務情報
    Cremonini S.p.A. (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Cremonini S.p.A. (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Shell Pakistan Ltd (SHEL):企業の財務・戦略的SWOT分析
    Summary Shell Pakistan Ltd (Shell Pakistan), a subsidiary of Royal Dutch Shell plc is an oil and gas company that markets petroleum products and compressed natural gas. The company operates through three segments such as retail, lubricants and aviation. It retail segment offers a range of fuels such …
  • Marksmen Energy Inc (MAH):企業の財務・戦略的SWOT分析
    Summary Marksmen Energy Inc (Marksmen Energy), formerly Marksmen Resources Ltd is an oil and gas exploration and development company that explores and develops light oil assets in Ohio. The company acquires, explores, operates, mines, manages, produces and develops oil and gas properties in Western …
  • Russian Reinsurance Company
    Russian Reinsurance Company - Strategy, SWOT and Corporate Finance Report Summary Russian Reinsurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sompo Holdings, Inc. (8630):企業の財務・戦略的SWOT分析
    Sompo Holdings, Inc. (8630) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • AbbVie Inc (ABBV)-製薬・医療分野:企業M&A・提携分析
    Summary AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company focuses on providing drugs in immunology, cancer, neuroscience and virology …
  • Emgesa SA ESP:電力:M&Aディール及び事業提携情報
    Summary Emgesa SA ESP (Emgesa), a subsidiary of Enel, is an energy utility that generates and trades electricity. The company produces power from hydro, coal, and oil and gas; and procures energy from generator and trader agents in the wholesale market. It owns thermal stations: Cartagena and Martin …
  • Akbank TAS (AKBNK):企業の財務・戦略的SWOT分析
    Akbank TAS (AKBNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆